Immunic (NASDAQ:IMUX) Lowered to Sell Rating by StockNews.com
Immunic (NASDAQ:IMUX – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. Several other brokerages have also recently weighed in on IMUX. HC Wainwright reaffirmed a “buy” rating and set a $10.00 price target on shares of Immunic […]
Immunic (NASDAQ:IMUX – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. Several other brokerages have also recently weighed in on IMUX. HC Wainwright reaffirmed a “buy” rating and set a $10.00 price target on shares of Immunic […]
